J clin oncol. 2022 40 16s
WebJun 1, 2024 · Results: Forty-two patients were enrolled. The ORR was 54.8% (95% CI, 38.7 to 70.2). In 39 efficacy-evaluable patients, the ORR was 59.0% (95% CI, 42.1 to 74.4); the disease control rate was 94.9% (95% CI, 82.7 to 99.4). The median PFS was 9.4 months (95% CI, 8.0 to 14.6). The median overall survival was not reached. WebJun 1, 2024 · Recommendations: Clinicians may use Onco type DX, MammaPrint, Breast Cancer Index (BCI), and EndoPredict to guide adjuvant endocrine and chemotherapy in …
J clin oncol. 2022 40 16s
Did you know?
WebAm. J. Clin. Oncol. Cancer Clin. Trials. The American Journal of Clinical Oncology is a bimonthly, peer-reviewed, scientific, oncology journal, published by Lippincott Williams & … WebJun 8, 2024 · A meta-analysis and review of the world literature found that histological subtype of renal cell carcinoma significantly affects survival in the era of partial nephrectomy in patients with pathologic T1a renalcell carcinoma. 1 Kunkle DA, Egleston BL, Uzzo RG. Excise, ablate or observe: the small renal mass dilemma – a meta-analysis and …
WebApr 11, 2024 · Finally, 11 high-quality RCT with delicate design (complete studies published between 2013 and 2024, including 1687 patients with recurrent platinum-resistant ovarian cancer) were included in this network meta-analysis. A flowchart describing the literature selection process is shown in Figure 1. FIGURE 1 Figure 1 Literature screening flowchart. WebApr 2, 2024 · Proton Image-guided Radiation Assignment for Therapeutic Escalation via Selection of locally advanced head and neck cancer patients [PIRATES]: A Phase I safety and feasibility trial of MRI-guided adaptive particle radiotherapy. Clin Transl Radiat Oncol. 2024 Nov 11;32:35-40. doi: 10.1016/j.ctro.2024.11.003. eCollection 2024 Jan.
WebApr 29, 2024 · Kayama T, Sato S, Sakurada K, Mizusawa J, Nishikawa R, Narita Y, Sumi M, Miyakita Y, Kumabe T, Sonoda Y, et al. Effects of surgery with salvage stereotactic radiosurgery versus surgery with whole-brain radiation therapy in patients with one to four brain metastases (JCOG0504): A phase III, noninferiority, randomized controlled trial. J … WebApr 8, 2024 · Clinical data from a report found significantly shorter progression-free survival and overall survival (OS), poorer baseline performance status, an increased chance of having chemo-refractory disease, and a higher proportion of liver and bone metastases in SCLC patients whose samples effectively generated CDX.
WebNov 9, 2024 · Summary of Evidence. Background. In 2024, over 160,000 men in the United States (U.S.) were diagnosed with prostate cancer, which accounted for 9.6% of all new cancer diagnoses. 1 Clinically localized prostate cancer accounts for ~80% of newly diagnosed cases. 1 The NCCN, classifies these men into risk groups based on clinical and …
WebApr 12, 2024 · Date accessed: October 16, 2024. Google Scholar; Incidence of GBC was determined using Globocan 2024 data, using the top quartile (≥1.1 GBC cases per 100,000 … buggy flexifoilWebThe Journal of Clinical Oncology Latest Journal's Impact IF 2024-2024 is 50.739. More Journal of Clinical Oncology Journal's Impact Trend, Prediction, Ranking & Key Factor … crossbow cockingWebTo better define this benefit, pooled data from 12 registrational clinical trials investigating 1L ICI with or without chemotherapy (chemo) in patients with documented KRAS status … crossbow cocking rope ebayWebFeb 10, 2024 · Single-Agent Mosunetuzumab Shows Durable Complete Responses in Patients With Relapsed or Refractory B-Cell Lymphomas: Phase I Dose-Escalation Study J Clin Oncol. 2024 Feb 10;40(5):481-491.doi: 10.1200/JCO.21.00931. Epub 2024 Dec 16. Authors Lihua E Budde 1 , Sarit Assouline 2 , Laurie H Sehn 3 crossbow cocking crankWebApr 6, 2024 · In 2024, ASCO launched living clinical practice guidelines for systemic therapy for patients with stage IV non–small-cell lung cancer (NSCLC) with 1 and without driver alterations 2 and both have been updated recently. 3 - 6 Based on routine literature searches (up to November 30, 2024), this version of the stage IV NSCLC without driver … buggy flip 360 radiocommandéWebDec 28, 2024 · Daratumumab is an anti-CD38 monoclonal antibody indicated for the treatment of MM. The addition of daratumumab to proteasome inhibitor and … buggy foodsWeb13 rows · Journal of Clinical Oncology. Journal Abbreviation: J CLIN ONCOL. Journal ISSN: 0732-183X. Year. Impact Factor (IF) Total Articles. Total Cites. 2024 (2024 update) 50.717. buggy fleece